Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients

BackgroundRapid and accurate pathogen diagnosis is an urgent unmet clinical need for recurrent urinary tract infection (RUTI) in kidney transplant recipients (KTRs). Metagenomic next-generation sequencing (mNGS) may offer another strategy for diagnosing uropathogens but remains to be studied.Methods...

Full description

Bibliographic Details
Main Authors: Wenjing Duan, Yongguang Yang, Jingge Zhao, Tianzhong Yan, Xiangyong Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.901549/full
_version_ 1811340780247187456
author Wenjing Duan
Yongguang Yang
Jingge Zhao
Tianzhong Yan
Xiangyong Tian
author_facet Wenjing Duan
Yongguang Yang
Jingge Zhao
Tianzhong Yan
Xiangyong Tian
author_sort Wenjing Duan
collection DOAJ
description BackgroundRapid and accurate pathogen diagnosis is an urgent unmet clinical need for recurrent urinary tract infection (RUTI) in kidney transplant recipients (KTRs). Metagenomic next-generation sequencing (mNGS) may offer another strategy for diagnosing uropathogens but remains to be studied.MethodsNineteen KTRs with RUTI were collected in this study. The uropathogens were detected and compared by mNGS and urine culture, respectively. Modifications of the anti-infection strategy were also assessed.ResultsRich and diverse pathogens were revealed by mNGS. mNGS was significantly higher than culture in total positive rate (100.0% vs. 31.6%; p < 0.01) and in identification rates for bacteria (89.5% vs. 31.6%; p < 0.01), for viruses (57.9% vs. 0; p < 0.01), and for fungi (42.1% vs. 0; p < 0.01), respectively. mNGS identified a significantly higher proportion of mixed infections than culture (89.5% vs. 10.5%; p < 0.01). The anti-infection therapies were adjusted in two (33.3%) and 12 (76.9%) cases guided by culture and mNGS, respectively.ConclusionmNGS has more remarkable etiological diagnostic performance compared with urine culture for KTRs with RUTI to guide anti-infection strategies and, in turn, protect the graft.
first_indexed 2024-04-13T18:46:58Z
format Article
id doaj.art-24bdc1d5bc6146c5a4c58035ddb90759
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-13T18:46:58Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-24bdc1d5bc6146c5a4c58035ddb907592022-12-22T02:34:33ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-08-011010.3389/fpubh.2022.901549901549Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipientsWenjing Duan0Yongguang Yang1Jingge Zhao2Tianzhong Yan3Xiangyong Tian4Department of the Clinical Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of the Clinical Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of the Clinical Research Center, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaDepartment of Urology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou, ChinaBackgroundRapid and accurate pathogen diagnosis is an urgent unmet clinical need for recurrent urinary tract infection (RUTI) in kidney transplant recipients (KTRs). Metagenomic next-generation sequencing (mNGS) may offer another strategy for diagnosing uropathogens but remains to be studied.MethodsNineteen KTRs with RUTI were collected in this study. The uropathogens were detected and compared by mNGS and urine culture, respectively. Modifications of the anti-infection strategy were also assessed.ResultsRich and diverse pathogens were revealed by mNGS. mNGS was significantly higher than culture in total positive rate (100.0% vs. 31.6%; p < 0.01) and in identification rates for bacteria (89.5% vs. 31.6%; p < 0.01), for viruses (57.9% vs. 0; p < 0.01), and for fungi (42.1% vs. 0; p < 0.01), respectively. mNGS identified a significantly higher proportion of mixed infections than culture (89.5% vs. 10.5%; p < 0.01). The anti-infection therapies were adjusted in two (33.3%) and 12 (76.9%) cases guided by culture and mNGS, respectively.ConclusionmNGS has more remarkable etiological diagnostic performance compared with urine culture for KTRs with RUTI to guide anti-infection strategies and, in turn, protect the graft.https://www.frontiersin.org/articles/10.3389/fpubh.2022.901549/fullmetagenomic next-generation sequencing (mNGS)kidney transplantationrecurrent urinary tract infection (RUTI)uropathogensanti-infective treatment
spellingShingle Wenjing Duan
Yongguang Yang
Jingge Zhao
Tianzhong Yan
Xiangyong Tian
Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
Frontiers in Public Health
metagenomic next-generation sequencing (mNGS)
kidney transplantation
recurrent urinary tract infection (RUTI)
uropathogens
anti-infective treatment
title Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
title_full Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
title_fullStr Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
title_full_unstemmed Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
title_short Application of metagenomic next-generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
title_sort application of metagenomic next generation sequencing in the diagnosis and treatment of recurrent urinary tract infection in kidney transplant recipients
topic metagenomic next-generation sequencing (mNGS)
kidney transplantation
recurrent urinary tract infection (RUTI)
uropathogens
anti-infective treatment
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.901549/full
work_keys_str_mv AT wenjingduan applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients
AT yongguangyang applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients
AT jinggezhao applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients
AT tianzhongyan applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients
AT xiangyongtian applicationofmetagenomicnextgenerationsequencinginthediagnosisandtreatmentofrecurrenturinarytractinfectioninkidneytransplantrecipients